![]() |
|
|
Vol. 288, Issue 2, 472-477, February 1999
Institute of Neurology (G.R., C.L.P.D., H.M.) and
Department of
Anesthesiology (R.D., J.E., C.M.R.),
University Hospital Nijmegen, the
Netherlands, and Department of Psychology/(Nijmegen Institute for
Cognition and Information) , University of Nijmegen, the Netherlands
(C.M.R.).
Although monotherapy in epilepsy treatment is frequently advocated,
this is not based on studies with equal drug loads. This study was
performed to investigate the experimental background of polytherapy
with standardized drug loads. Dose-dependent effects on grip strength,
accelerod performance, and spontaneous behavior of rats was used to
study the effect of combining valproate and ethosuximide. The potency
of the drugs (combination) was obtained by fitting the sigmoid
Emax equation to the data. Drug interaction was assessed
using the isobologram method and quantified by comparing equivalent
drug loads with their 95% confidence intervals. We found that the
effects of valproate and ethosuximide combine in a simple additive way
in the grip strength experiment as well as in the accelerod experiment.
In the behavioral studies, however, a higher drug load of the
combination was needed to obtain the same amount of sedation,
signifying infra-additivity. Infra-additivity of sedative effects is an
important finding because this is by far the most frequent side effect
mentioned in human studies. However, assessment of the therapeutic
effect of the combination will have to be completed before a preference
for mono- or polytherapy, based on the balance of adverse effects and
efficacy, can be expressed.
This article has been cited by other articles:
![]() |
I. Avis, A. Martinez, J. Tauler, E. Zudaire, A. Mayburd, R. Abu-Ghazaleh, F. Ondrey, and J. L. Mulshine Inhibitors of the Arachidonic Acid Pathway and Peroxisome Proliferator-Activated Receptor Ligands Have Superadditive Effects on Lung Cancer Growth Inhibition Cancer Res., May 15, 2005; 65(10): 4181 - 4190. [Abstract] [Full Text] [PDF] |
||||